Physician profile
Brian C Kolski
NPI 1851449896
$533,676.01
in general payments reported to CMS, 2019-2025
58 companies · $90K in 2025
The $90K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $82K · 2020: $42K · 2021: $106K · 2022: $74K · 2023: $54K · 2024: $86K · 2025: $90K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $79K · Travel and Lodging: $44K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $42K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $29K · Food and Beverage: $22K · Honoraria: $13K · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $79,065.60 |
| Travel and Lodging | $43,527.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,163.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $29,125.00 |
| Food and Beverage | $21,896.02 |
| Honoraria | $13,200.00 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $107,762.90 | 2019-2025 | Impella |
| Shockwave Medical, INC | $84,167.62 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $79,859.18 | 2019-2025 | Navitor, Diamondback Coronary, Mitraclip |
| Penumbra, INC. | $75,256.77 | 2019-2024 | Indigo System |
| Cardiovascular Systems INC. | $52,999.78 | 2019-2023 | Diamondback Peripheral, Diamondback Coronary |
| Cordis US Corp. | $40,726.46 | 2022-2025 | Selution Slr Pta, Mynx Control Venous, Selution Slr Ptca |
| Edwards Lifesciences Corporation | $38,997.36 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia, Evoque |
| Medtronic, INC. | $18,584.60 | 2021-2025 | Corevalve Evolut R, Micra, Linq II |
| Avertix Medical, INC | $12,728.10 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $5,639.79 | 2022-2025 | |
| Biotronik INC. | $2,381.73 | 2019-2022 | |
| Medtronic Vascular, INC. | $1,834.06 | 2019-2020 | |
| Vesalio, INC. | $1,500.00 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $1,230.43 | 2019-2025 | |
| Chiesi USA, INC. | $1,046.38 | 2019-2025 | Kengreal |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saranas, INC. | $825.87 | 2021-2023 | |
| Amgen INC. | $772.31 | 2019-2025 | Repatha, Repatha |
| Aop Health US, LLC | $692.81 | 2025 | Rapiblyk |
| Acutus Medical, INC. | $684.15 | 2020-2022 | |
| Impulse Dynamics (USA) INC. | $525.69 | 2021-2025 | Optimizer |
| Pfizer INC. | $514.26 | 2019-2025 | |
| Cvrx, INC. | $511.02 | 2022-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $458.79 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $374.83 | 2019-2023 | Jardiance |
| Inari Medical, INC. | $338.08 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $304.08 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $294.47 | 2019-2025 | Lifevest |
| Astellas Pharma US INC | $290.53 | 2022 | |
| Siemens Medical Solutions USA, INC. | $288.68 | 2019-2022 | |
| Cathworks, INC. | $238.12 | 2019-2020 | |
| Atricure, INC. | $196.58 | 2019-2024 | |
| Boston Scientific Corporation | $196.34 | 2019-2025 | Avvigo Guidance System, General - Balloon Catheters, Watchman Flx |
| Kestra Medical Technology Services, INC. | $185.28 | 2022-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals Lp | $140.33 | 2019-2024 | Fasenra, Farxiga, Wainua |
| Biosense Webster, INC. | $130.99 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $100.10 | 2023-2025 | Camzyos, Eliquis |
| Infobionic, INC | $81.24 | 2025 | Mome Device |
| Kowa Pharmaceuticals America, INC. | $70.20 | 2019-2022 | |
| Scpharmaceuticals INC. | $67.34 | 2023-2024 | |
| Portola Pharmaceuticals, LLC | $67.01 | 2019 | |
| Philips North America LLC | $58.86 | 2022-2024 | (P84) Igt Devices Systems |
| Merck Sharp & Dohme LLC | $55.81 | 2022-2025 | Verquvo |
| W. L. Gore & Associates, INC. | $53.31 | 2020 | |
| Terumo Medical Corporation | $47.17 | 2022-2023 | R2p Misago |
| Angiodynamics, INC. | $45.81 | 2020-2022 | |
| Cardiva Medical, INC. | $44.17 | 2024-2025 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f |
| Heartflow, INC. | $39.49 | 2019 | |
| Irhythm Technologies, INC. | $38.51 | 2021 | |
| Esperion Therapeutics, INC. | $36.04 | 2021-2023 | Nexletol |
| Alnylam Pharmaceuticals INC. | $35.94 | 2025 | Amvuttra |
| Novo Nordisk INC | $34.03 | 2023-2024 | Ozempic |
| Acist Medical Systems, INC. | $27.97 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $21.40 | 2024 | Opsumit, Uptravi |
| Lundbeck LLC | $19.46 | 2019 | |
| Teleflex LLC | $14.91 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $14.73 | 2024 | Arcalyst |
| Bardy Diagnostics, INC. | $12.90 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$30.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kolski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.